ROTHBLATT MARTINE A, CHAIR, CEO, reported a transaction classified as withholding at UNITED THERAPEUTICS Corp involving 15559.000000 shares for an estimated $8341491.08. Reported holdings after the transaction were 40513.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
Form 4 relationship flags and nearby filing context
Chairperson & CEO
Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
Represents the number of shares withheld by United Therapeutics for tax purposes, upon vesting of restricted stock units.
Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
Shares received upon vesting of performance-based restricted stock units on March 15, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. These restricted stock…
0 other filings
0 recent txs